SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Ward & Hagon Contract Renewal

19 Feb 2021 07:00

RNS Number : 6556P
Warpaint London PLC
19 February 2021
Β 

Β 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

Β 

Ward & Hagon Contract Renewal

Β 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics andΒ owner of the W7 and Technic brands, announces that it has renewed its contract with Ward & Hagon Management Consulting LLP ("Ward & Hagon") (the "Contract").

Β 

As announced on 6 February 2020, the Company appointed Ward & Hagon, a provider of practical business solutions, to assist it in implementing its strategic growth plan. As a result of a successful initial period, whereby they assisted the Group in accessing new retail channels (including Tesco) the Company is pleased to announce that the Contract with Ward & Hagon, has been renewed for a further 12 months.

Β 

The Contract has a total annual value of Β£210,000 (which will be satisfied from the Group's operating cash flows), and includes the services of Paul Hagon, an executive director of the Company and Martyn Ward, amongst other members of the Ward & Hagon team. In addition Ward & Hagon will be paid a commission of 3% on all sales generated from their introductions in the 12 month period from the point of first sale, and 4% on all sales generated from their introductions in the 12 month period thereafter.

Β 

The board is of the view that the services provided under the Contract represent value to shareholders through assisting the Company achieving is near term objectives. Accordingly, Ward & Hagon will continue to focus on assisting the Group access new retail channels both in the UK and overseas.

Β 

Related Party Transaction

Β 

Paul Hagon, an executive director of Warpaint, is a member of Ward & Hagon. Accordingly the renewal of the contract is classified as a related party transaction pursuant to the AIM Rules for Companies. The independent directors of the Company (being all executive and non-executive directors except Mr Hagon), having consulted with N+1 Singer, the Company's Nominated Adviser, consider that the terms of the Contract renewal are fair and reasonable insofar as the Company's shareholders are concerned.

Β 

Β 

Enquiries:

Warpaint London

Sam BaziniΒ - Chief Executive Officer

Eoin MacleodΒ - Managing Director

Neil RodolΒ - Chief Financial Officer

Β 

c/o IFC

Β 

N+1 Singer (Nominated Adviser & Joint Broker)

Shaun Dobson, Jen Boorer, Alex Bond - Corporate FinanceTom Salvesen - Corporate Broking

020 7496 3000

Β 

Shore Capital (Joint Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

Β 

020 7408 4090

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Graham Herring

Florence Chandler

020 3934 6630

Β 

Β 

Warpaint London plc

Β 

Warpaint is made up of two divisions.

Β 

The largest division sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using our other own brand names of Man'stuff, Body Collection, Vintage, Very Vegan, and Chit Chat.

Β 

The other division trades in close-out and excess inventory of branded cosmetics and fragrances from around the world.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTEAEAPFSEFEAA
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM and Posting of Annual Report
29th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSNotice of Results
9th Apr 20269:41 amRNSBlock Listing Return
17th Feb 20261:34 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSRule 19.6(c) confirmation re Brand Architekts
9th Feb 20262:21 pmRNSCompletion of the acquisition of the Barry M brand
9th Feb 20267:00 amRNSAcquisition of Barry M brand & FY25 Trading Update
24th Nov 202512:16 pmRNSHolding(s) in Company
10th Nov 20252:06 pmRNSBLOCK LISTING RETURN
29th Oct 20252:52 pmRNSHolding(s) in Company
9th Oct 20251:36 pmRNSBlock listing Return
8th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
17th Sep 20259:12 amRNSHolding(s) in Company
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Results
21st Aug 20252:23 pmRNSHolding(s) in Company
19th Aug 20258:21 amRNSHolding(s) in Company
17th Jun 202510:46 amRNSResult of AGM
17th Jun 20257:00 amRNSAGM Statement
28th May 20252:43 pmRNSHolding(s) in Company
20th May 202512:01 pmRNSHolding(s) in Company
20th May 20257:30 amRNSNotice of AGM and Posting of Annual Report
13th May 20254:54 pmRNSBlock listing Interim Return
29th Apr 20257:00 amRNSResults for the year ended 31 December 2024
14th Apr 20257:00 amRNSNotice of Results
9th Apr 20253:07 pmRNSBLOCK LISTING RETURN
24th Mar 20251:38 pmRNSAnnouncement pursuant to AIM rule 13
13th Feb 20253:18 pmGNWForm 8.3 - Warpaint London Plc
13th Feb 20251:52 pmRNSForm 8.3 - Warpaint London plc
13th Feb 202512:17 pmRNSForm 8.3 - Warpaint London Plc
13th Feb 202511:50 amRNSForm 8.5 (EPT/RI)
13th Feb 202511:24 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
12th Feb 20255:56 pmRNSForm 8.3 - Warpaint London plc Amend
12th Feb 20253:46 pmRNSDirector/PDMR Dealing
12th Feb 20253:37 pmRNSApplication for Admission of Shares and TVR
12th Feb 20253:25 pmRNSReplacement: Scheme Effective
12th Feb 20253:10 pmRNSForm 8.3 - Warpaint London plc
12th Feb 20252:41 pmGNWForm 8.3 - Warpaint London Plc
12th Feb 20252:19 pmRNSForm 8.3 - Warpaint London Plc
12th Feb 202512:05 pmPRNForm 8.3 - Warpaint London Plc
12th Feb 202511:48 amRNSForm 8.3 - Warpaint London plc
12th Feb 202511:35 amRNSForm 8.3 - Warpaint London PLC
12th Feb 202510:59 amRNSForm 8.5 (EPT/RI)
12th Feb 202510:54 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 20253:04 pmGNWForm 8.3 - Warpaint London Plc
11th Feb 202512:19 pmRNSForm 8.3 - Warpaint London plc
11th Feb 202511:03 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 202510:49 amRNSForm 8.5 (EPT/RI)
11th Feb 202510:36 amRNSForm 8.3 - Warpaint London plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.